Pathology/Lab Coding Alert

You Be the Coder:

Try Your Hand at This Bone Marrow Case

Question: Our pathologist evaluated a bone marrow biopsy and clot section from a patient diagnosed with metastatic breast carcinoma. The pathology report states, “The metastatic carcinoma is estrogen receptor (ER) positive and progesterone receptor (PR) negative. HER2/neu studies performed by immunohistochemistry show 1+ membrane stain, which is equivocal. HER2/neu analysis by FISH was attempted, but tumor was not available on deeper sections to complete this study.”

Which CPT Codes should I use to bill this case? The pathologists performed all analyses using   manual methods.


Illinois Subscriber


Answer: Use the following CPT codes to report this case:

• 88305 (Level IV--Surgical pathology, gross and microscopic examination, bone marrow, biopsy) This code describes the pathologist’s bone-marrow biopsy evaluation.

• 88305 (… cell block, any source) Report an additional 88305 for the pathologist’s examination of the cell block prepared from the clot.

• 2 x 88342 (Immunohistochemistry [including tissue immunoperoxidase], each antibody) You should use 88342 for the ER/PR stains because the report simply states “positive” or “negative,” meaning that this is a qualitative result. Because the code states, “each antibody,” you should list two units of 88342--one for estrogen receptor and one for progesterone receptor.

• 88360 (Morphometric analysis, tumor immunohistochemistry [e.g., Her-2/neu, estrogen receptor/progesterone receptor], quantitative or semiquantitative, each antibody; manual) Unlike the ER/PR results, which are qualitative, the Her-2/neu results are semiquantitative. The fact that the report states “1+ membrane stain” means that the pathologist “scores” the slide using a semiquantitative scale rather than simply noting the presence or absence of Her-2/neu antibody and giving a positive or negative qualitative report. 
 
You should not bill the Her-2/neu analysis by FISH because the pathologist did not complete the study and did not provide any diagnostic results from the attempt.
Codify by AAPC
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Pathology/Lab Coding Alert

View All
Subscribe to newsletter